NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Today Media President Rob Martinelli states small businesses that drive Delaware’s economy deserve better than shortsighted tax hikes.Read More